Indian firms may garner up to 50% of USFDA nod share in 2023
NEW DELHI: Indian companies are expected to secure a 48-50 percent share of approvals for new drugs from the US ...
©2024 Blitz India Media -Building A New Nation
Tag: USFDA
Sun Pharma recalls over 24K prefilled syringes of generic medication in the US
Team Blitz India NEW DELHI: Drug major Sun Pharmaceutical Industries is recalling pre-filled syringes of a drug, used to treat ...
Recent News
India Growth Story: Start-ups, Trade, Data and Khadi
From start-ups to solar, India’s power to empower story NEW DELHI, 13 October — India had a few hundred start-ups...
Read moreDetails